Scaleup programmes

Back to programmes


IP Group

Finance and Risk Capital

Impact for scaleups


UK companies backed


Follow-on investments


Investments outside of London


Growth-stage investments

Key sectors

Impact ventures / Social Impact Life Sciences & Biotech Building & Construction Manufacturing / Advanced Manufacturing Creative, digital, film, games & media Professional services Defence & security Technology & Communications Engineering / Advanced Engineering Transport & Logistics Environmental Science & Technology Farming, fisheries & forestry Finance Food & drink Healthcare

The 22 year-old IP Group is an FTSE-250 listed IP commercialisation company which has helped to develop more than 500 companies. With a focus on life sciences, deeptech and cleantech, it invests in university spin-outs at seed, venture and growth stages and assists them with the commercialisation of their new products and services, with technology transfer, IP licensing and protection. It continues to invest in portfolio companies as they scale. 

It describes itself as “one of the largest investors in university and other research-based companies in the world; the most prolific investor in deeptech companies in the UK and the second most prolific in Europe.”

The firm has a long-term partnership model with UK universities and developed an approach to supporting businesses from “cradle to maturity,” including assistance with executive search and recruitment and raising growth stage capital from co-investors. It currently has partnerships with 17 UK universities, six US universities and nine universities in Australia and New Zealand. 

The company owns Parkwalk Advisors, an active EIS investor in university spin-outs of ‘hard science’ companies, and has stakes in Oxford Sciences Innovation and Cambridge Innovation Capital. Other UK scaleups in its portfolio include Ultraleap, Crescendo Biologics, First Light Fusion and Istesso.

IP Group website